Literature DB >> 29464273

[Perianal inflammatory diseases : Classification and imaging].

A-O Schäfer1.   

Abstract

During the past 30 years, classifications and scoring systems have been developed in order to evaluate and objectify the degree and activity of anorectal fistulas. Only a few of these disease-specific instruments have been adopted into daily clinical routine. Generally, clinicians tend to use global medical judgement rather than numeric activity indices, which often seem complex and time consuming. Activity scores in Crohn disease, however, appeared to be very useful in clinical trials regarding evaluation of therapy response. Thus, activity indices must be simple and reproducible. The years 1976 and 1995, in which the Parks Classification and Perianal Disease Activity Index (PDAI) were established, can be considered milestone years for classifying patients with anorectal fistulizing disease. These instruments should be recognized at present as the gold standard for evaluating the complexity as well as the severity of anorectal fistulas and perianal Crohn disease.

Entities:  

Keywords:  Acne inversa; Anal fistula; Crohn disease; Inflammation; Magnetic resonance imaging

Mesh:

Year:  2018        PMID: 29464273     DOI: 10.1007/s00117-018-0368-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

1.  MR imaging classification of perianal fistulas and its implications for patient management.

Authors:  J Morris; J A Spencer; N S Ambrose
Journal:  Radiographics       Date:  2000 May-Jun       Impact factor: 5.333

2.  [Chronic inflammatory bowel diseases: Crohn disease and ulcerative colitis. 1: Etiology and pathogenesis, diagnosis. Diagnostic imaging in Crohn disease].

Authors:  S Feuerbach; J Schölmerich
Journal:  Radiologe       Date:  2000-03       Impact factor: 0.635

Review 3.  [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].

Authors:  T Ochsenkühn; M Sackmann; B Göke
Journal:  Radiologe       Date:  2003-01       Impact factor: 0.635

Review 4.  AGA technical review on perianal Crohn's disease.

Authors:  William J Sandborn; Victor W Fazio; Brian G Feagan; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

5.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

6.  [Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014].

Authors:  J C Preiß; B Bokemeyer; H J Buhr; A Dignaß; W Häuser; F Hartmann; K R Herrlinger; B Kaltz; P Kienle; W Kruis; T Kucharzik; J Langhorst; S Schreiber; B Siegmund; A Stallmach; E F Stange; J Stein; J C Hoffmann
Journal:  Z Gastroenterol       Date:  2014-12-04       Impact factor: 2.000

Review 7.  Review article: Crohn's disease: monitoring disease activity.

Authors:  R Sostegni; M Daperno; N Scaglione; A Lavagna; R Rocca; A Pera
Journal:  Aliment Pharmacol Ther       Date:  2003-06       Impact factor: 8.171

8.  Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study.

Authors:  Manon L W Ziech; Cristina Lavini; Shandra Bipat; Cyriel Y Ponsioen; Anje M Spijkerboer; Pieter C F Stokkers; Aart J Nederveen; Jaap Stoker
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

9.  Assessment of anal fistulas with high-resolution subtraction MR-fistulography: comparison with surgical findings.

Authors:  Oliver Schaefer; Christian Lohrmann; Mathias Langer
Journal:  J Magn Reson Imaging       Date:  2004-01       Impact factor: 4.813

10.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

Authors:  E J Irvine
Journal:  J Clin Gastroenterol       Date:  1995-01       Impact factor: 3.062

View more
  1 in total

1.  Magnetic resonance imaging findings in patients with initial manifestations of perianal fistulas.

Authors:  Khawaja Bilal Waheed; Waseem Jan Shah; Bilal Altaf; Muhammad Amjad; Fawad Hameed; Sana Wasim; Muhammad Zia UlHassan; Zahra Mohammed Abuabdullah; Selvin Nesaraj Rajamonickam; Zechriah Jebakumar Arulanatham
Journal:  Ann Saudi Med       Date:  2020-02-06       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.